ADHD medications, including stimulants, non-stimulants, and antidepressants, help manage symptoms by balancing neurotransmitters in the brain. However, these medications can also lead to side effects such as anxiety and sleep disturbances. The ADHD Medication Guide, developed and maintained by Dr. Andrew Adesman, comprises a comparison chart of FDA-approved stimulants and non-stimulants that is updated more frequently. The US Food and Drug Administration (FDA) has approved several kinds of medications for ADHD that include stimulants (methylphenidate-based and amphetamine-based products) and nonstimulants including atomoxetine and antihypertensives (alpha-2 adrenergic agonists). Types of treatment for ADHD include behavior therapy and medications. Treatment recommendations vary by age group. For younger children, the American Academy of Pediatrics (AAP) recommends parent training in behavior management as the first line of treatment, before medication is tried. ADHD medication treats the symptoms of attention-deficit/hyperactivity disorder (ADHD), such as hyperactivity and impulsivity. ADHD medications work by increasing the levels of chemicals (neurotransmitters) in your brain. Get to know the side effects of various types of ADD and ADHD medications, and drug treatments, including stimulants, nonstimulants, and antidepressants. Compare risks and benefits of common medications used for ADHD. Find the most popular drugs, view ratings and user reviews. This guide explains how ADHD medications work, how different kinds of medication might affect your child and what side affects he might experience. ADHD is commonly treated with prescription medications. See a full list of drugs, including stimulants and nonstimulants for children and adults. The guide provides dosing information and images of medications indicated for the treatment of ADHD by the FDA. In clinical practice, this guide may be used to assist patients in identifying medications previously tried and may allow clinicians to identify ADHD medication options for the future.